Blindness and deafness in some infants and sickle cell are among the conditions cured in recent gene therapy trials.
The World Health Organization also recommends using a z-score for diagnosing faltering weight, in addition to growth charts.
A valved holding chamber with high drug delivery performance may reduce wheezing severity and hospitalizations more ...
MedPage Today on MSN
Psilocybin failed to live up to hype for treatment-resistant depression
Researchers questioned psychedelic's true efficacy in unblinded trials ...
Collaboration with one of the world's largest animal health companies expected to accelerate TRUFORMA adoption, expand installed base, and drive recurring diagnostic revenue ANN ARBOR, MI / ACCESS ...
Zoetis (ZTS) looks undervalued: 17.3x forward P/E, $150 target with 25% upside, plus dividends/buybacks—see key risks and ...
The MarketWatch News Department was not involved in the creation of this content.-- 43% of pet owners report that their pets experienced parasite infections, with 75% seeking clea ...
The Kenya Times on MSN
10,000 patients enrolled in Kenya’s fight against chronic diseases
The Access to Healthcare program by Boehringer Ingelheim, a research-driven biopharmaceutical company, in partnership with ...
Global survey reveals pet owners lack awareness of parasite risks and seek clearer prevention advice
Veterinarians are seen as the most trusted source of pet health advice. “Small acts of love. Big moments of life” campaign is launching on World Parasite Awareness Day to increase understanding of how ...
The new €3.2M (US$3.7M) research lab will investigate immunogenic cell death mechanisms in lung cancer to improve how existing therapies trigger immune response.
Adults with moderate to severe plaque psoriasis saw the greatest mean quality-of-life gains with biologic therapy whereas home phototherapy offered lower costs for patients and payers, according to a ...
One of St. Joseph’s top employers announced Monday that 60 employees in manufacturing and supply will no longer have roles moving forward. An official with Boehringer Ingelheim ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results